Thymic adenocarcinoma presenting as an incidental mediastinal mass

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Primary thymic adenocarcinoma represents an exceptionally rare malignancy, for which the cornerstone of therapy is margin-negative resection, with radiation and systemic therapy reserved for invasive and advanced disease. Thymic adenocarcinoma has not been previously reported in the setting of a concomitant malignancy, as reported herein. Case presentation: We present a case of a 55-year-old previously healthy male diagnosed with acute myeloid leukemia, also found to have a mediastinal mass. Evaluation of the mediastinal mass with tumor markers, biopsies, and next-generation sequencing proved non-diagnostic, while he was simultaneously treated with induction chemotherapy to prevent leukemia-related blast crisis. After completing and recovering from induction chemotherapy, he underwent successful thymectomy during a chemotherapy holiday, with a margin-negative resection of thymic adenocarcinoma. He has subsequently recovered and undergone successful allogeneic hematopoietic stem cell transplant. Conclusions: We present a case of synchronous adult acute myeloid leukemia and primary thymic adenocarcinoma requiring a tailored approach for management of simultaneous malignancies.

Cite

CITATION STYLE

APA

O’Shea, A. E., Nissen, A. P., Bowen, D. K., Barnett, T. L., & Gustafson, J. D. (2022). Thymic adenocarcinoma presenting as an incidental mediastinal mass. Journal of Cardiothoracic Surgery, 17(1). https://doi.org/10.1186/s13019-022-02000-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free